Pharmaceutical Online Videos

  1. Advancing Viral Safety With Next-Generation Sequencing 6/4/2026

    Discover how advanced sequencing and bioinformatics technologies are helping shape the future of viral safety assessment in biopharmaceutical manufacturing.

  2. PCI Pharma Services Capabilities Update May 2026: Combination Products & Drug Delivery 6/1/2026

    Explore the capabilities, infrastructure, and innovations driving scalable clinical-to-commercial solutions for today’s increasingly complex injectable combination products.

  3. Asahi Kasei Bioprocess - Made In The USA 5/29/2026

    Discover how combining Japanese precision with American ingenuity creates reliable bioprocess filtration solutions built for consistent, batch-after-batch manufacturing performance.

  4. Bend Bioscience Capabilities Update May 2026: Highly Potent Drug Development & Manufacturing 5/29/2026

    Discover how Bend Bioscience is scaling High Science + High Service through expanded capacity and targeted investments.

  5. Recipharm Capabilities Update May 2026: Highly Potent Drug Development & Manufacturing 5/29/2026

    Bringing a high potency product to market is rarely straightforward, especially when timelines slip, API is scarce and processes don't scale as planned.

  6. IDT Biologika Capabilities Update May 2026: Mammalian Cell Culture 5/29/2026

    This webinar provides an expert overview of how IDT Biologika leverages advanced mammalian cell culture platforms to enable efficient, scalable biopharmaceutical development and manufacturing.

  7. FUJIFILM Biotechnologies Capabilities Update May 2026: Mammalian Cell Culture 5/29/2026

    With over 30 years of experience, FUJIFILM Biotechnologies specializes in developing and manufacturing biopharmaceuticals using microbial, mammalian, and host/virus systems.

  8. Resilience Capabilities Update May 2026: Large Molecule 5/29/2026

    An integrated network unites biologics, cell therapy, and drug product with digital systems and teams to speed tech transfer, scale reliably, and ensure delivery from development to commercial.

  9. Rentschler Biopharma Capabilities Update May 2026: Large Molecule 5/29/2026

    Rentschler Biopharma is a global leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. 

  10. Nanoform Capabilities Update May 2026: Combination Products & Drug Delivery 5/28/2026

    See how novel nanoforming technologies can enable alternative delivery routes and support high-concentration injectable and pulmonary formulation development beyond the limits of traditional approaches.